Alpha Healthcare Acquisition Corp.
AHACU
NASDAQ Global Select12.08
USD
+0.88
- -
CIK
0001818382
ISIN
US0207512023
CUSIP
020751202
Return %
Stock
S&P500
1Y
- -
26.53
3Y
- -
76.60
5Y
20.77
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Rajiv Sarman Shukla
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 1177 Avenue of The Americas New York City NY United States of America
- IPO Date
- Sep 18, 2020
- CIK
- 0001818382
- Website
- constellationalpha.com
- Similar Companies
- Business
- Alpha Healthcare Acquisition Corp. (AHACU) is a blank check company formed to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses, primarily targeting opportunities in the healthcare industry including services, therapeutics, devices, diagnostics, healthcare technology, and animal health; it offers no operational products or services beyond its SPAC structure of redeemable units comprising Class A common stock and warrants exercisable at $11.50 per share. Incorporated in Delaware in 2020 and headquartered at 1177 Avenue of the Americas, 5th Floor, New York, New York 10036, the company raised $100 million in its initial public offering on September 18, 2020, led by Chairman and CEO Rajiv Shukla with a 24-month tenor to complete a deal. In August 2021, it completed a business combination with Humacyte, Inc., a developer of bioengineered human tissues and advanced tissue constructs, resulting in the combined entity trading as Humacyte (NASDAQ: HUMA; HUMAW) following approval on August 24, 2021, with gross proceeds of approximately $245 million including PIPE financing; AHACU units persist as legacy securities tied to the post-merger structure.
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Alpha Healthcare Acquisition Corp. - AHAC
Regenerative Tissue Developer Humacyte Going Public Via SPAC
Alpha Healthcare Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing November 9, 2020